Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Vasomotor Symptoms”

Showing 11 of 0 results

Large-scale testing (Phase 3)Study completedNCT04003142
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

Who this might be right for
Hot Flashes
Astellas Pharma Global Development, Inc. 501
Not applicableStudy completedNCT04553029
What this trial is testing

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

Who this might be right for
Menopause
Astellas Pharma Singapore Pte. Ltd. 3,399
Testing effectiveness (Phase 2)Ended earlyNCT01015677
What this trial is testing

MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

Who this might be right for
Moderate to Severe Vasomotor Symptoms in PostmenopausalWomen
Merck Sharp & Dohme LLC 99
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Testing effectiveness (Phase 2)Study completedNCT00604825
What this trial is testing

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Who this might be right for
Menopausal and Female Climacteric States
GlaxoSmithKline 356
Large-scale testing (Phase 3)Study completedNCT04090957
What this trial is testing

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

Who this might be right for
Vasomotor SymptomsMenopausal Symptoms
Estetra 1,015
Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Large-scale testing (Phase 3)Study completedNCT04234204
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 302
Large-scale testing (Phase 3)Not Yet RecruitingNCT07829653
What this trial is testing

Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 100
Testing effectiveness (Phase 2)Study completedNCT02100540
What this trial is testing

Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women

Who this might be right for
PMSHot Flashes
Yung Shin Pharm. Ind. Co., Ltd. 58
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation